PLoS ONE (Jan 2015)
Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0121207.].
PLoS ONE (Jan 2015)
[This corrects the article DOI: 10.1371/journal.pone.0121207.].